Search

Learn how a bone marrow transplant saved the life of a child with a rare blood disease.

… Monday, September 19, 2016 Summary People with blood diseases such as Wiskott-Aldrich syndrome can sometimes be treated successfully with bone marrow transplantation , a technique pioneered by MSK’s Richard O’Reilly . Kim Okochi’s heart sank when nurses told her that her newborn son, Finn, had low platelets

Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.

… Thursday, March 9, 2017 Summary Leptomeningeal metastasis , when cancer spreads to spinal fluid, is one of the most challenging types of metastatic cancer to treat. Now research is providing clues about how this happens, as well as pointing to possible treatments. Highlights Between 5 and 10 percent

In patients with resected pancreatic ductal adenocarcinoma, alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency genes were associated with favorable prognoses.

… Thursday, July 16, 2020 In patients with resected pancreatic ductal adenocarcinoma (PDAC), alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency (HRD) genes were associated with favorable prognoses, according to a study by our research

Learn about important advances in the treatment of pancreatic cancer.

… Thursday, June 5, 2025 Many people have questions about pancreatic cancer and its prognosis. MSK surgeon-scientist and pancreatic cancer expert Vinod Balachandran, MD, discusses why the disease is so hard to detect, what the latest treatment options are, and how promising research may improve survival

The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering.

… Thursday, April 28, 2022 Cycle for Survival, the movement to beat rare cancers, made history by surpassing $300 million in total funds raised through its signature stationary-cycling events. Since 2007, more than 1 million participants worldwide, including patients, caregivers, survivors, as well as

Learn how MSK uses the watch-and-wait approach to rectal cancer, which can preserve people's quality of life by successfully treating rectal cancer without removing the rectum.

… Friday, February 28, 2025 There’s an alternative for treating some patients with  rectal cancer that makes it possible to avoid  surgical removal of the rectum and the related side effects, which can include changes to sexual function and fertility and the possibility of a permanent ostomy bag — a pouch

Descubra cómo MSK utiliza el enfoque de observación y espera para el cáncer de recto, que permite preservar la calidad de vida de los pacientes al tratar con éxito el cáncer de recto sin necesidad de extirpar el recto.

… Friday, February 28, 2025 Existe una alternativa para tratar a algunos pacientes con cáncer de recto que permite evitar la extirpación quirúrgica del recto y los efectos secundarios relacionados, que pueden incluir cambios en la función sexual y la fertilidad y la posibilidad de tener que usar una bolsa

Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation, or chemotherapy.

… Sunday, April 27, 2025 An approach pioneered at Memorial Sloan Kettering Cancer Center (MSK) that caused rectal cancer tumors with a specific genetic mutation to disappear in 100% of clinical trial participants has been expanded to treat other types of cancer, including stomach (gastric) , colon , esophageal

Obtenga información sobre un ensayo clínico en el que se utilizó únicamente inmunoterapia para tratar a personas con varios tipos diferentes de cáncer, lo que significa que no tuvieron que someterse a cirugía, radioterapia ni quimioterapia.

… Sunday, April 27, 2025 Un enfoque en el que Memorial Sloan Kettering Cancer Center (MSK) fue pionero y que hizo que los tumores de cáncer de recto con una mutación genética específica desaparecieran en el 100 % de los participantes en el ensayo clínico se ha ampliado para tratar otros tipos de cáncer

Using genetic engineering, Memorial Sloan Kettering Cancer Center (MSK) physician-scientist Christopher Klebanoff, MD, has led a team of researchers to create a “cloak” that protects cancer-fighting T white blood cells, such as chimeric antigen receptor T cells, from self-destructing. During cancer immunotherapy, immune cells often undergo a form of cellular suicide, termed apoptosis, which can limit the therapy’s effectiveness. The use of “genetic cloaking” prevents immune cell apoptosis, enhancing the effectiveness of cellular immunotherapies for liquid and solid cancers in mouse models. This new technique is also effective in protecting human cancer-fighting immune cells. These findings lay the groundwork for a potentially universal gene-engineering strategy to safely increase the potency of cellular immunotherapies for a broad range of cancers.

… Tuesday, January 29, 2019 Bottom Line: Using genetic engineering, Memorial Sloan Kettering Cancer Center (MSK) physician-scientist Christopher Klebanoff, MD , has led a team of researchers to create a “cloak” that protects cancer-fighting T white blood cells, such as chimeric antigen receptor T cells